Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,140.40
(
0.52%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.64
(
2.38%
)
Bitcoin
74,785.57
(
-0.08%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 130075

Wednesday, 11/02/2011 8:39:10 PM

Wednesday, November 02, 2011 8:39:10 PM

Post# of 257253

TEVA said it would be "premature" to submit an NDA at this time for laquinimod and will be working with FDA to design an additional trial for the relapsing-remitting multiple sclerosis (RRMS) product.



http://www.biocentury.com/dailynews/company/2011-11-02/teva-says-laquinimod-nda-submission-premature

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now